Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySat, 08 Jun 2024 16:39:39 +0200Mon, 08 Apr 2024 09:56:05 +0200Opinion/decision on a Paediatric investigation plan (PIP): Trixeo Aerosphere, Budesonide,Formoterol (fumarate),Glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0068/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002063-pip01-16-m02Opinion/decision on a Paediatric investigation plan (PIP): Trixeo Aerosphere, Budesonide,Formoterol (fumarate),Glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0068/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002063-pip01-16-m02Mon, 08 Apr 2024 09:56:05 +0200Human medicine